glp 1 generations GLP-1: Transforming weight loss and the food industry 9 Companies Developing Next-Generation GLP-1

Medications including Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound were heavily marketed by pharmaceutical companies such as Novo Nordisk and Eli Lilly for blood sugar management, appetite reduction, and obesity treatment

It has no side effects and also used as booster dose with whitening injection

Dietary adjustments often provide significant relief, including eating smaller, more frequent meals rather than large portions, avoiding high-fat or spicy foods that may exacerbate symptoms, and eating slowly to allow for better digestion

As the body adapts to weight loss, it increases appetite hormones and slows metabolism